Cannabidiol, or CBD, is popping up everywhere, from creams to coffee to prescriptions. CBD is one of the key compounds in cannabis plants, though it doesn’t cause marijuana’s characteristic high. It’s being touted as a treatment for all kinds of ailments, but the evidence for some uses is thin.
Meanwhile, CBD is already a $1 billion industry, and some on Wall Street think it could reach $16 billion, aided in part by a recent change in US law that made some CBD legal.
Sativa Group PLC (NEX:SATI) is a seed to Consumer medicinal cannabis and cannabidiol (CBD) wellness business, focused on the smart-sourcing of the raw material, advanced extraction, manufacture, testing, distribution, and research & development of medicinal cannabis and CBD products.